Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1986 1
1990 1
1991 1
1994 1
1996 1
1998 3
1999 3
2000 1
2001 1
2002 4
2003 7
2005 2
2006 1
2007 4
2008 6
2009 1
2010 1
2012 4
2013 4
2014 5
2015 5
2016 2
2017 2
2018 2
2019 1
2020 2
2021 1
2022 16
2023 8
2024 9
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Long-Term Outcomes of Rituximab-Treated Adult Patients with Podocytopathies.
Gauckler P, Matyjek A, Kapsia S, Marinaki S, Quintana LF, Diaz MM, King C, Griffin S, Ramachandran R, Odler B, Eller K, Artan AS, Mirioglu S, Busch M, Schaepe M, Turkmen K, Cheung CK, Pepper RJ, Juarez GF, Pascual J, Auñón P, García-Carro C, Rodriguez A, Alberici F, Luzardo L, Chebotareva N, Schönermarck U, Fernández L, Radhakrishnan J, Guaman K, Peleg Y, Hoisnard L, Audard V, Papasotiriou M, Krnanska N, Tesar V, Hruskova Z, Bruchfeld A, Stangou M, Lioulios G, Faguer S, Ribes D, Salhi S, Windpessl M, Galešić K, Crnogorac M, Zagorec N, Mayer G, Kronbichler A; RITERM Study Team. Gauckler P, et al. Among authors: juarez gf. J Am Soc Nephrol. 2025 Apr 1;36(4):668-678. doi: 10.1681/ASN.0000000520. Epub 2024 Oct 16. J Am Soc Nephrol. 2025. PMID: 39431468
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy.
Fernández-Juárez G, Rojas-Rivera J, Logt AV, Justino J, Sevillano A, Caravaca-Fontán F, Ávila A, Rabasco C, Cabello V, Varela A, Díez M, Martín-Reyes G, Diezhandino MG, Quintana LF, Agraz I, Gómez-Martino JR, Cao M, Rodríguez-Moreno A, Rivas B, Galeano C, Bonet J, Romera A, Shabaka A, Plaisier E, Espinosa M, Egido J, Segarra A, Lambeau G, Ronco P, Wetzels J, Praga M; STARMEN Investigators. Fernández-Juárez G, et al. Kidney Int. 2021 Apr;99(4):986-998. doi: 10.1016/j.kint.2020.10.014. Epub 2020 Nov 7. Kidney Int. 2021. PMID: 33166580 Free article. Clinical Trial.
Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial.
Pérez de la Ossa N, Abilleira S, Jovin TG, García-Tornel Á, Jimenez X, Urra X, Cardona P, Cocho D, Purroy F, Serena J, San Román Manzanera L, Vivanco-Hidalgo RM, Salvat-Plana M, Chamorro A, Gallofré M, Molina CA, Cobo E, Davalos A, Ribo M; RACECAT Trial Investigators. Pérez de la Ossa N, et al. JAMA. 2022 May 10;327(18):1782-1794. doi: 10.1001/jama.2022.4404. JAMA. 2022. PMID: 35510397 Free PMC article. Clinical Trial.
Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials.
Barbour SJ, Ronco P, Praga M, Fervenza FC, Induruwage D, Zhu B, Debiec H, Fernández-Juárez G, Caravaca-Fontán F, Cattran DC; GEMRITUX, MENTOR and STARMEN investigators. Barbour SJ, et al. Clin J Am Soc Nephrol. 2025 Apr 14;20(6):854-865. doi: 10.2215/CJN.0000000694. Clin J Am Soc Nephrol. 2025. PMID: 40228233
Acoustic emissions from spin crossover complexes.
Kamel SM, Daróczi L, Tóth LZ, Beke DL, Juárez GG, Cobo S, Salmon L, Molnár G, Bousseksou A. Kamel SM, et al. Among authors: juarez gg. J Mater Chem C Mater. 2024 Mar 19;12(16):5757-5765. doi: 10.1039/d4tc00495g. eCollection 2024 Apr 25. J Mater Chem C Mater. 2024. PMID: 38680543 Free PMC article.
A REVIEW OF KETAMINE ABUSE AND DIVERSION.
Sassano-Higgins S, Baron D, Juarez G, Esmaili N, Gold M. Sassano-Higgins S, et al. Among authors: juarez g. Depress Anxiety. 2016 Aug;33(8):718-27. doi: 10.1002/da.22536. Epub 2016 Jun 22. Depress Anxiety. 2016. PMID: 27328618 Review.
Deferasirox Derivatives: Ligands for the Lanthanide Series.
Mangel DN, Juarez GJ, Carpenter SH, Steinbrueck A, Lynch VM, Yang J, Sedgwick AC, Tondreau A, Sessler JL. Mangel DN, et al. Among authors: juarez gj. J Am Chem Soc. 2023 Oct 11;145(40):22206-22212. doi: 10.1021/jacs.3c08375. Epub 2023 Sep 26. J Am Chem Soc. 2023. PMID: 37751361
Central American and Caribbean consensus for the treatment of MS, NMOSD, and MOGAD.
Ramirez DA, Gracia F, Jimenez AJD, Alvarez PM, Candelario AE, Castro-Escobar R, Rivas AIP, Diaz de la Fe A, Camaño DRD, Sotelo OAD, Valle LAG, Juarez GMAG, Torres EL, Vindas AP, Rivera LIP, Sanchez NER, Salinas LCR, Pujols BS, Santana SBV, Angeles IZ, Pena JA, Rivera VM. Ramirez DA, et al. Among authors: juarez gmag. Mult Scler Relat Disord. 2025 Mar;95:106334. doi: 10.1016/j.msard.2025.106334. Epub 2025 Feb 9. Mult Scler Relat Disord. 2025. PMID: 39954489
Cyclopentadienyl capped thorium(IV) porphyrinoid complex.
Mangel DN, Brewster JT, Juarez GJ, Lynch VM, Sessler JL. Mangel DN, et al. Among authors: juarez gj. Chem Commun (Camb). 2024 Jan 23;60(8):1020-1022. doi: 10.1039/d3cc05283d. Chem Commun (Camb). 2024. PMID: 38170623
102 results